Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1970 2
1971 4
1972 4
1973 3
1974 2
1975 3
1978 1
1979 1
1982 3
1986 1
1987 1
1988 3
1989 3
1990 3
1991 2
1992 3
1994 2
1996 1
1997 1
1998 1
1999 1
2000 4
2001 3
2002 4
2003 3
2004 6
2006 2
2007 6
2008 3
2009 4
2010 3
2011 3
2012 4
2013 4
2014 1
2015 4
2016 6
2017 7
2018 6
2019 6
2020 6
2021 9
2022 10
2023 6
2024 8
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics.
Korn D, Sheffer-Levi S, Eitan-Wexler M, Ben-Shushan S, Avner M, Hirshhorn N, Bracha M, Mali A, Shereberk-Hasidim R, Merims S, Popovtzer A, Molho-Pessach V, Lotem M, Cohen JE. Korn D, et al. Among authors: lotem m. JAAD Int. 2025 Sep 29;24:1-3. doi: 10.1016/j.jdin.2025.09.003. eCollection 2026 Feb. JAAD Int. 2025. PMID: 41244853 Free PMC article. No abstract available.
Facts and Hopes: Toward the Next Quantum Leap in Melanoma.
Flaherty KT, Aplin AE, Davies MA, Hacohen N, Herlyn M, Hoon D, Hwu P, Lotem M, Mulé J, Wargo JA, Fisher DE. Flaherty KT, et al. Among authors: lotem m. Clin Cancer Res. 2025 Jul 15;31(14):2882-2889. doi: 10.1158/1078-0432.CCR-25-0278. Clin Cancer Res. 2025. PMID: 40407722 Review.
RORc-expressing immune cells negatively regulate tertiary lymphoid structure formation and support their pro-tumorigenic functions.
Cinnamon E, Stein I, Zino E, Rabinovich S, Shovman Y, Schlesinger Y, Salame TM, Reich-Zeliger S, Albrecht T, Roessler S, Schirmacher P, Lotem M, Ben-Neriah Y, Parnas O, Pikarsky E. Cinnamon E, et al. Among authors: lotem m. J Hepatol. 2025 Jun;82(6):1050-1067. doi: 10.1016/j.jhep.2024.12.015. Epub 2024 Dec 20. J Hepatol. 2025. PMID: 39710149 Free article.
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Long GV, Carlino MS, McNeil C, Ribas A, Gaudy-Marqueste C, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance AM, Daud AI, Hamid O, Larkin J, Yao L, Singh R, Lal R, Robert C. Long GV, et al. Among authors: lotem m. Ann Oncol. 2024 Dec;35(12):1191-1199. doi: 10.1016/j.annonc.2024.08.2330. Epub 2024 Sep 15. Ann Oncol. 2024. PMID: 39306585 Free article. Clinical Trial.
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.
Christopoulos P, Harel M, McGregor K, Brody Y, Puzanov I, Bar J, Elon Y, Sela I, Yellin B, Lahav C, Raveh S, Reiner-Benaim A, Reinmuth N, Nechushtan H, Farrugia D, Bustinza-Linares E, Lou Y, Leibowitz R, Kamer I, Zer Kuch A, Moskovitz M, Levy-Barda A, Koch I, Lotem M, Katzenelson R, Agbarya A, Price G, Cheley H, Abu-Amna M, Geldart T, Gottfried M, Tepper E, Polychronis A, Wolf I, Dicker AP, Carbone DP, Gandara DR. Christopoulos P, et al. Among authors: lotem m. JCO Precis Oncol. 2024 Mar;8:e2300555. doi: 10.1200/PO.23.00555. JCO Precis Oncol. 2024. PMID: 38513170 Free PMC article.
162 results